Genetic polymorphisms and plasma levels of interleukin-22 contribute to the development of nonsmall cell lung cancer

DNA and Cell Biology

Volumn 33, Issue 10, 2014, Pages 705-714

  Liu, Fei ^a   Pan, Xufeng ^b   Zhou, Lin ^a   Zhou, Jian ^c   Chen, Bin ^c   Shi, Jianxin ^b   Gao, Wen ^b   Lu, Liming ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

^c FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 22; INTERLEUKIN DERIVATIVE; INTERLEUKIN-22;

ADENOCARCINOMA; ADULT; ALLELE; ARTICLE; CHINESE; CONTROLLED STUDY; GENE FREQUENCY; GENOTYPE; HAPLOTYPE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MIDDLE AGED; NON SMALL CELL LUNG CANCER; PROTEIN BLOOD LEVEL; SINGLE NUCLEOTIDE POLYMORPHISM; SQUAMOUS CELL CARCINOMA; BLOOD; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; CASE CONTROL STUDY; CHINA; EPIDEMIOLOGY; FEMALE; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETICS; INFLAMMATION; LUNG NEOPLASMS; MALE; RISK; SEQUENCE TAGGED SITE;

ADENOCARCINOMA; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; CHINA; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INFLAMMATION; INTERLEUKINS; LUNG NEOPLASMS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK; SEQUENCE TAGGED SITES;

EID: 84907535553     PISSN: 10445498     EISSN: 15577430     Source Type: Journal    
DOI: 10.1089/dna.2014.2432     Document Type: Article

References (32)

1. Balkwill, F., and Mantovani, A. (2001). Inflammation and cancer: Back to Virchow? Lancet 357, 539-545.
2. Coussens, L.M., and Werb, Z. (2002). Inflammation and cancer. Nature 420, 860-867.
3. Curd, L.M., Favors, S.E., and Gregg, R.K. (2012). Pro-Tumour activity of interleukin-22 in HPAFII human pancreatic cancer cells. Clin Exp Immunol 168, 192-199.
4. Domingo-Domenech, E., Benavente, Y., Gonzalez-Barca, E., Montalban, C., Guma, J., Bosch, R., Wang, S.S., Lan, Q., Whitby, D., Fernandez de Sevilla, A., Rothman, N., and de Sanjose, S. (2007). Impact of interleukin-10 polymorphisms (-1082 and-3575) on the survival of patients with lymphoid neoplasms. Haematologica 92, 1475-1481.
5. Dubinett, S.M., and Kradin, R.L. (1993). Cytokine immunotherapy of non-small cell lung cancer. Reg Immunol 5, 232-243.
6. Duhen, T., Geiger, R., Jarrossay, D., Lanzavecchia, A., and Sallusto, F. (2009). Production of interleukin 22 but not interleukin 17 by a subset of human skin-homing memory T cells. Nat Immunol 10, 857-863.
7. Eun, Y.G., Shin, I.H., Lee, Y.C., Shin, S.Y., Kim, S.K., Chung, J.H., and Kwon, K.H. (2013). Interleukin 22 polymorphisms and papillary thyroid cancer. J Endocrinol Invest 36, 584-587.
8. Ferlay, J., Autier, P., Boniol, M., Heanue, M., Colombet, M., and Boyle, P. (2007). Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol 18, 581-592.
9. Harrison, C. (2013). Cancer: IL-22: Linking inflammation and cancer. Nat Rev Drug Discov 12, 504.
10. Huang, M., Wang, J., Lee, P., Sharma, S., Mao, J.T., Meissner, H., Uyemura, K., Modlin, R., Wollman, J., and Dubinett, S.M. (1995). Human non-small cell lung cancer cells express a type 2 cytokine pattern. Cancer Res 55, 3847-3853.
11. Hussain, S.K., Madeleine, M.M., Johnson, L.G., Du, Q., Galloway, D.A., Daling, J.R., Malkki, M., Petersdorf, E.W., and Schwartz, S.M. (2013). Nucleotide variation in IL-10 and IL-12 and their receptors and cervical and vulvar cancer risk: A hybrid case-parent triad and case-control study. Int J Cancer 133, 201-213.
12. Ikeuchi, H., Kuroiwa, T., Hiramatsu, N., Kaneko, Y., Hiromura, K., Ueki, K., and Nojima, Y. (2005). Expression of interleukin-22 in rheumatoid arthritis: Potential role as a proinflammatory cytokine. Arthritis Rheum 52, 1037-1046.
13. Jiang, R., Zhang, C., Xia, Y., Qian, X., Wang, X., and Sun, B. (2013). Serum interleukin-22 level is a negative prognostic indicator in patients with HBV-related hepatocellular carcinoma. Hepatology 59, 1208.
14. Kamiya, T., Hatanaka, H., Abe, Y., Kijima, H., Yamazaki, H., Ohnishi, Y., Inoue, H., Ueyama, Y., Osamura, Y., and Nakamura, M. (2003). Interleukin-10 expression is closely correlated with the expression of granulocyte-macrophage colony-stimulating factor in non-small cell lung cancer. Anticancer Res 23, 2909-2913.
15. Kirchberger, S., Royston, D.J., Boulard, O., Thornton, E., Franchini, F., Szabady, R.L., Harrison, O., and Powrie, F. (2013). Innate lymphoid cells sustain colon cancer through production of interleukin-22 in a mouse model. J Exp Med 210, 917-931.
16. Kiyohara, C., Horiuchi, T., Takayama, K., and Nakanishi, Y. (2014). Genetic polymorphisms involved in the inflammatory response and lung cancer risk: A case-control study in Japan. Cytokine 65, 88-94.
17. Kobold, S., Volk, S., Clauditz, T., Kupper, N.J., Minner, S., Tufman, A., Duwell, P., Lindner, M., Koch, I., Heidegger, S., Rothenfuer, S., Schnurr, M., Huber, R.M., Wilczak, W., and Endres, S. (2013). Interleukin-22 is frequently expressed in small-And large-cell lung cancer and promotes growth in chemotherapy-resistant cancer cells. J Thorac Oncol 8, 1032-1042.
18. Kopp, T.I., Friis, S., Christensen, J., Tjonneland, A., and Vogel, U. (2013). Polymorphisms in genes related to inflammation, NSAID use, and the risk of prostate cancer among Danish men. Cancer Genet 206, 266-278.
19. Kradin, R.L., Boyle, L.A., Preffer, F.I., Callahan, R.J., Barlai-Kovach, M., Strauss, H.W., Dubinett, S., and Kurnick, J.T. (1987). Tumor-derived interleukin-2-dependent lymphocytes in adoptive immunotherapy of lung cancer. Cancer Immunol Immunother 24, 76-85.
20. Lejeune, D., Dumoutier, L., Constantinescu, S., Kruijer, W., Schuringa, J.J., and Renauld, J.C. (2002). Interleukin-22 (IL-22) activates the JAK/STAT, ERK, JNK, and p38 MAP kinase pathways in a rat hepatoma cell line. Pathways that are shared with and distinct from IL-10. J Biol Chem 277, 33676-33682.
21. Lin, W.W., and Karin, M. (2007). A cytokine-mediated link between innate immunity, inflammation, and cancer. J Clin Invest 117, 1175-1183.
22. Mitra, A., Raychaudhuri, S.K., and Raychaudhuri, S.P. (2012). Functional role of IL-22 in psoriatic arthritis. Arthritis Res Ther 14, R65.
23. Murray, J.L., Thompson, P., Yoo, S.Y., Do, K.A., Pande, M., Zhou, R., Liu, Y., Sahin, A.A., Bondy, M.L., and Brewster, A.M. (2013). Prognostic value of single nucleotide polymorphisms of candidate genes associated with inflammation in early stage breast cancer. Breast Cancer Res Treat 138, 917-924.
24. Naher, L., Kiyoshima, T., Kobayashi, I., Wada, H., Nagata, K., Fujiwara, H., Ookuma, Y.F., Ozeki, S., Nakamura, S., and Sakai, H. (2012). STAT3 signal transduction through interleukin-22 in oral squamous cell carcinoma. Int J Oncol 41, 1577-1586.
25. Sobin, L.H., Gospodarowicz, M.K., and Wittekind, C. (2011). TNM Classification of Malignant Tumours. ( John Wiley & Sons, Hoboken
26. Thompson, C.L., Plummer, S.J., Tucker, T.C., Casey, G., and Li, L. (2010). Interleukin-22 genetic polymorphisms and risk of colon cancer. Cancer Causes Control 21, 1165-1170.
27. Vivier, E., Spits, H., and Cupedo, T. (2009). Interleukin-22-producing innate immune cells: New players in mucosal immunity and tissue repair? Nat Rev Immunol 9, 229-234.
28. Wang, H., Taverna, D., Stram, D.O., Fortini, B.K., Cheng, I., Wilkens, L.R., Burnett, T., Makar, K.W., Lindor, N.M., Hopper, J.L., Gallinger, S., Baron, J.A., Haile, R., Kolonel, L.N., Henderson, B.E., Newcomb, P.A., Casey, G., Duggan, D., Ulrich, C.M., and Le Marchand, L. (2013). Genetic variation in the inflammation and innate immunity pathways and colorectal cancer risk. Cancer Epidemiol Biomarkers Prev 22, 2094-2101.
29. Wolk, K., Witte, E., Witte, K., Warszawska, K., and Sabat, R. (2010). Biology of interleukin-22. In Seminars in Immunopathology. (Springer, Heidelberg), pp. 17-31.
30. Wu, T., Cui, L., Liang, Z., Liu, C., Liu, Y., and Li, J. (2013). Elevated serum IL-22 levels correlate with chemoresistant condition of colorectal cancer. Clin Immunol 147, 38-39.
31. Xue, H., Wang, Y.C., Lin, B., An, J., Chen, L., Chen, J., and Fang, J.Y. (2012). A meta-Analysis of interleukin-10-592 promoter polymorphism associated with gastric cancer risk. PLoS One 7, e39868.
32. Zhang, W., Chen, Y., Wei, H., Zheng, C., Sun, R., Zhang, J., and Tian, Z. (2008). Antiapoptotic activity of autocrine interleukin-22 and therapeutic effects of interleukin-22-small interfering RNA on human lung cancer xenografts. Clin Cancer Res 14, 6432-6439.